Association of MTHFR C677T Polymorphism with Susceptibility to Migraine in the Chinese population

Neuroscience Letters

Volumn 549, Issue , 2013, Pages 78-81

  An, Xing Kai ^a   Lu, Cong Xia ^a   Ma, Qi Lin ^a,b   Zhang, Xiao Rong ^b   Burgunder, Jean Marc ^c   Lin, Qing ^a   Qu, Hong Li ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

ACE I D; MAOA T941G; Migraine; MTHFR C677T; Polymorphism; TNF G252A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AMINE OXIDASE (FLAVIN CONTAINING); DIPEPTIDYL CARBOXYPEPTIDASE; LYMPHOTOXIN; RESTRICTION ENDONUCLEASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL;

ACE I/D; MAOA T941G; MIGRAINE; MTHFR C677T; POLYMORPHISM; TNF-Β G252A;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOTOXIN-ALPHA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE DISORDERS; MONOAMINE OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880755172     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.028     Document Type: Article

References (32)

1. Asuni C., Stochino M.E., Cherchi A., Manchia M., Congiu D., Manconi F., Squassina A., Piccardi M.P., Del Zompo M. Migraine and tumour necrosis factor gene polymorphism. An association study in a Sardinian sample. J. Neurol. 2009, 256:194-197.
2. Cevoli S., Mochi M., Scapoli C., Marzocchi N., Pierangeli G., Pini L.A., Cortelli P., Montagna P. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur. J. Neurol. 2006, 13:1009-1013.
3. Colson N.J., Lea R.A., Quinlan S., Griffiths L.R. The role of vascular and hormonal genes in migraine susceptibility. Mol. Genet. Metab. 2006, 88:107-113.
4. Corominas R., Sobrido M.J., Ribases M., Cuenca-Leon E., Blanco-Arias P., Narberhaus B., Roig M., Leira R., Lopez-Gonzalez J., Macaya A., Cormand B. Association study of the serotoninergic system in migraine in the Spanish population. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2010, 153B:177-184.
5. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nothen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., Beckmann H., Bellodi L., Lesch K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999, 8:621-624.
6. Di Minno M.N., Tremoli E., Coppola A., Lupoli R., Di Minno G. Homocysteine and arterial thrombosis: challenge and opportunity. Thromb. Haemost. 2010, 103:942-961.
7. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., Rozen R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
8. Ghosh J., Joshi G., Pradhan S., Mittal B. Investigation of TNFA 308G>A and TNFB 252G>A polymorphisms in genetic susceptibility to migraine. J. Neurol. 2010, 257:898-904.
9. S.Headache Classification Subcommittee of the International Headache The international classification of headache disorders: 2nd edition. Echolalia 2004, 24(Suppl. 1):9-160.
10. Ishii M., Shimizu S., Sakairi Y., Nagamine A., Naito Y., Hosaka Y., Naito Y., Kurihara T., Onaya T., Oyamada H., Imagawa A., Shida K., Takahashi J., Oguchi K., Masuda Y., Hara H., Usami S., Kiuchi Y. MAOA, MTHFR, and TNF-beta genes polymorphisms and personality traits in the pathogenesis of migraine. Mol. Cell. Biochem. 2012, 363:357-366.
11. Joshi G., Pradhan S., Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J. Neurol. Sci. 2009, 277:133-137.
12. Kaunisto M.A., Kallela M., Hamalainen E., Kilpikari R., Havanka H., Harno H., Nissila M., Sako E., Ilmavirta M., Liukkonen J., Teirmaa H., Tornwall O., Jussila M., Terwilliger J., Farkkila M., Kaprio J., Palotie A., Wessman M. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Echolalia 2006, 26:1462-1472.
13. Ligthart L., Boomsma D.I., Martin N.G., Stubbe J.H., Nyholt D.R. Migraine with aura and migraine without aura are not distinct entities: further evidence from a large Dutch population study. Twin Res. Hum. Genet. 2006, 9:54-63.
14. Lin J.J., Wang P.J., Chen C.H., Yueh K.C., Lin S.Z., Harn H.J. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol. Taiwan 2005, 14:120-125.
15. Maher B.H., Griffiths L.R. Identification of molecular genetic factors that influence migraine. Mol. Genet. Genomics 2011, 285:433-446.
16. Nyholt D.R., Gillespie N.G., Heath A.C., Merikangas K.R., Duffy D.L., Martin N.G. Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet. Epidemiol. 2004, 26:231-244.
17. Piane M., Lulli P., Farinelli I., Simeoni S., De Filippis S., Patacchioli F.R., Martelletti P. Genetics of migraine and pharmacogenomics: some considerations. J. Headache Pain 2007, 8:334-339.
18. Pizza V., Agresta A., Agresta A., Lamaida E., Lamaida N., Infante F., Capasso A. Migraine and genetic polymorphisms: an overview. Open Neurol. J. 2012, 6:65-70.
19. Rubino E., Ferrero M., Rainero I., Binello E., Vaula G., Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Echolalia 2009, 29:818-825.
20. Sacco S., Ricci S., Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Echolalia 2012, 32:785-795.
21. Samaan Z., Gaysina D., Cohen-Woods S., Craddock N., Jones L., Korszun A., Owen M., Mente A., McGuffin P., Farmer A. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol. 2011, 11:66.
22. Schurks M. Genetics of migraine in the age of genome-wide association studies. J. Headache Pain 2012, 13:1-9.
23. Schurks M., Rist P.M., Bigal M.E., Buring J.E., Lipton R.B., Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009, 339:b3914.
24. Schurks M., Rist P.M., Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache 2010, 50:588-599.
25. Schurks M., Zee R.Y., Buring J.E., Kurth T. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 2009, 72:650-656.
26. Schurks M., Zee R.Y., Buring J.E., Kurth T. MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women. Echolalia 2010, 30:447-456.
27. Spector J.T., Kahn S.R., Jones M.R., Jayakumar M., Dalal D., Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am. J. Med. 2010, 123:612-624.
28. Stovner L.J. Migraine prophylaxis with drugs influencing the renin-angiotensin system. Eur. J. Neurol. 2007, 14:713-714.
29. Tietjen E.G. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Echolalia 2007, 27:981-987.
30. Todt U., Freudenberg J., Goebel I., Netzer C., Heinze A., Heinze-Kuhn K., Gobel H., Kubisch C. MTHFR C677 T polymorphism and migraine with aura. Ann. Neurol. 2006, 60:621-622.
31. Trabace S., Brioli G., Lulli P., Morellini M., Giacovazzo M., Cicciarelli G., Martelletti P. Tumor necrosis factor gene polymorphism in migraine. Headache 2002, 42:341-345.
32. Yu S., Liu R., Zhao G., Yang X., Qiao X., Feng J., Fang Y., Cao X., He M., Steiner T. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 2012, 52:582-591.